Factors predicting survival in patients with proximal gastric carcinoma involving the esophagus

World Journal of Gastroenterology

Volumn 18, Issue 27, 2012, Pages 3602-3609

  Zhang, Yi Fen ^a   Shi, Jiong ^a   Yu, Hui Ping ^a   Feng, An Ning ^a   Fan, Xiang Shan ^a   Lauwers, Gregory Y ^b   Mashimo, Hiroshi ^b   Gold, Jason S ^b   Chen, Gang ^a   Huang, Qin ^a,b  

^a MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Cancer; Esophagus; Gastroesophageal junction; Staging; Stomach

Indexed keywords

ADULT; AGED; AGING; ARTICLE; CANCER GRADING; CANCER INVASION; CANCER LOCALIZATION; CANCER PROGNOSIS; CANCER SIZE; CANCER STAGING; CORRELATION ANALYSIS; DISTANT METASTASIS; ESOPHAGUS CARCINOMA; FEMALE; HELICOBACTER INFECTION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LOWER ESOPHAGUS SPHINCTER; LYMPH NODE METASTASIS; LYMPH VESSEL METASTASIS; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PREDICTIVE VALUE; RISK FACTOR; SEX DIFFERENCE; STOMACH CARCINOMA; SURVIVAL TIME;

EID: 84864290981     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v18.i27.3602     Document Type: Article

References (37)

1. Rüdiger Siewert J, Feith M, Werner M, Stein HJ. Adenocarcinoma of the esophagogastric junction: results of surgical therapy based on anatomical/topographic classification in 1,002 consecutive patients. Ann Surg 2000; 232: 353-361.
2. Siewert JR, Stein HJ. Carcinoma of the gastroesophageal junction: classification, pathology and extent of resection. Dis Esophagus 1986; 9: 173-182.
3. de Manzoni G, Pedrazzani C, Pasini F, Di Leo A, Durante E, Castaldini G, Cordiano C. Results of surgical treatment of adenocarcinoma of the gastric cardia. Ann Thorac Surg 2002; 73: 1035-1040.
4. Mariette C, Castel B, Toursel H, Fabre S, Balon JM, Triboulet JP. Surgical management of and long-term survival after adenocarcinoma of the cardia. Br J Surg 2002; 89: 1156-1163.
5. Fang WL, Wu CW, Chen JH, Lo SS, Hsieh MC, Shen KH, Hsu WH, Li AF, Lui WY. Esophagogastric junction adenocarcinoma according to Siewert classification in Taiwan. Ann Surg Oncol 2009; 16: 3237-3244.
6. Ichikura T, Chochi K, Sugasawa H, Mochizuki H. Proposal for a new definition of true cardia carcinoma. J Surg Oncol 2007; 95: 561-566.
7. Kamangar F, Dawsey SM, Blaser MJ, Perez-Perez GI, Pietinen P, Newschaffer CJ, Abnet CC, Albanes D, Virtamo J, Taylor PR. Opposing risks of gastric cardia and noncardia gastric adenocarcinomas associated with Helicobacter pylori seropositivity. J Natl Cancer Inst 2006; 98: 1445-1452.
8. Huang Q, Zhang LH. The histopathologic spectrum of carcinomas involving the gastroesophageal junction in the Chinese. Int J Surg Pathol 2007; 15: 38-52.
9. Zhang LH, Huang Q. Changes in Incidences of Gastric Cardiac-gastroesophageal Junctional and Sub-cardiac Carcinomas in Nanjing of China: 20-year Retrospective Study from a Single Tertiary Medical Center. N Am J Med Sci 2009; 2: 35-38.
10. Huang Q, Fan XS, Feng AN, Qiang Z, Yu CG, Mashimo H, Lauwers GY. Distal Esophageal Adenocarcinoma Remains Rare Among Chinese Population: A Clinicopathologic Study of 211 Resection Cases. Gastroenterology 2011; 140: S670.
11. Huang Q, Fan X, Agoston AT, Feng A, Yu H, Lauwers G, Zhang L, Odze RD. Comparison of gastro-oesophageal junction carcinomas in Chinese versus American patients. Histopathology 2011; 59: 188-197.
12. Siewert JR, Stein HJ, Feith M. Adenocarcinoma of the esophago-gastric junction. Scand J Surg 2006; 95: 260-269.
13. American Joint Committee on Cancer. Esophagus and Esophagogastric Junction. In: AJCC Cancer Staging Manual. 7th ed. New York, NY: Springer, 2009.
14. Rizk NP, Venkatraman E, Bains MS, Park B, Flores R, Tang L, Ilson DH, Minsky BD, Rusch VW. American Joint Committee on Cancer staging system does not accurately predict survival in patients receiving multimodality therapy for esophageal adenocarcinoma. J Clin Oncol 2007; 25: 507-512.
15. Siewert JR, Stein HJ, Feith M, Bruecher BL, Bartels H, Fink U. Histologic tumor type is an independent prognostic parameter in esophageal cancer: lessons from more than 1,000 consecutive resections at a single center in the Western world. Ann Surg 2001; 234: 360-367; discussion 360-367.
16. Lagarde SM, ten Kate FJ, Reitsma JB, Busch OR, van Lanschot JJ. Prognostic factors in adenocarcinoma of the esophagus or gastroesophageal junction. J Clin Oncol 2006; 24: 4347-4355.
17. Lagarde SM, Reitsma JB, de Castro SM, Ten Kate FJ, Busch OR, van Lanschot JJ. Prognostic nomogram for patients undergoing oesophagectomy for adenocarcinoma of the oesophagus or gastro-oesophageal junction. Br J Surg 2007; 94: 1361-1368.
18. Westerterp M, Koppert LB, Buskens CJ, Tilanus HW, ten Kate FJ, Bergman JJ, Siersema PD, van Dekken H, van Lanschot JJ. Outcome of surgical treatment for early adenocarcinoma of the esophagus or gastro-esophageal junction. Virchows Arch 2005; 446: 497-504.
19. Whitson BA, Groth SS, Li Z, Kratzke RA, Maddaus MA. Survival of patients with distal esophageal and gastric cardia tumors: a population-based analysis of gastroesophageal junction carcinomas. J Thorac Cardiovasc Surg 2010; 139: 43-48.
20. Huang Q, Shi J, Feng A, Fan X, Zhang L, Mashimo H, Cohen D, Lauwers G. Gastric cardiac carcinomas involving the esophagus are more adequately staged as gastric cancers by the 7th edition of the American Joint Commission on Cancer Staging System. Mod Pathol 2011; 24: 138-146.
21. Schomas DA, Quevedo JF, Donahue JM, Nichols FC, Romero Y, Miller RC. The prognostic importance of pathologically involved celiac node metastases in node-positive patients with carcinoma of the distal esophagus or gastroesophageal junction: a surgical series from the Mayo Clinic. Dis Esophagus 2010; 23: 232-239.
22. Sons HU, Borchard F. Cancer of the distal esophagus and cardia. Incidence, tumorous infiltration, and metastatic spread. Ann Surg 1986; 203: 188-195.
23. Akiyama H, Tsurumaru M, Kawamura T, Ono Y. Principles of surgical treatment for carcinoma of the esophagus: analysis of lymph node involvement. Ann Surg 1981; 194: 438-446.
24. Siewert JR, Böttcher K, Stein HJ, Roder JD. Relevant prognostic factors in gastric cancer: ten-year results of the German Gastric Cancer Study. Ann Surg 1998; 228: 449-461.
25. Bando E, Yonemura Y, Taniguchi K, Fushida S, Fujimura T, Miwa K. Outcome of ratio of lymph node metastasis in gastric carcinoma. Ann Surg Oncol 2002; 9: 775-784.
26. Saito H, Fukumoto Y, Osaki T, Yamada Y, Fukuda K, Tatebe S, Tsujitani S, Ikeguchi M. Prognostic significance of the ratio between metastatic and dissected lymph nodes (n ratio) in patients with advanced gastric cancer. J Surg Oncol 2008; 97: 132-135.
27. Yu JW, Wu JG, Zheng LH, Zhang B, Ni XC, Li XQ, Jiang BJ. Influencing factors and clinical significance of the metastatic lymph nodes ratio in gastric adenocarcinoma. J Exp Clin Cancer Res 2009; 28: 55.
28. Wang W, Li YF, Sun XW, Chen YB, Li W, Xu DZ, Guan XX, Huang CY, Zhan YQ, Zhou ZW. Prognosis of 980 patients with gastric cancer after surgical resection. Chin J Cancer 2010; 29: 923-930.
29. Hyung WJ, Noh SH, Yoo CH, Huh JH, Shin DW, Lah KH, Lee JH, Choi SH, Min JS. Prognostic significance of metastatic lymph node ratio in T3 gastric cancer. World J Surg 2002; 26: 323-329.
30. Santiago JR, Osorio J, Gutierrez I, Perez N, Mufioz E, Veloso E, Marco C. Prognostic usefulness of lymph node ratio in understaged gastric cancer. Hepatogastroenterology 2009; 56: 1557-1561.
31. Nitti D, Marchet A, Olivieri M, Ambrosi A, Mencarelli R, Belluco C, Lise M. Ratio between metastatic and examined lymph nodes is an independent prognostic factor after D2 resection for gastric cancer: analysis of a large European monoinstitutional experience. Ann Surg Oncol 2003; 10: 1077-1085.
32. Lerut T, Coosemans W, Decker G, De Leyn P, Moons J, Nafteux P, Van Raemdonck D. Extended surgery for cancer ofthe esophagus and gastroesophageal junction. J Surg Res 2004; 117: 58-63.
33. Feith M, Stein HJ, Siewert JR. Pattern of lymphatic spread of Barrett's cancer. World J Surg 2003; 27: 1052-1057.
34. Eloubeidi MA, Desmond R, Arguedas MR, Reed CE, Wilcox CM. Prognostic factors for the survival of patients with esophageal carcinoma in the U.S.: the importance of tumor length and lymph node status. Cancer 2002; 95: 1434-1443.
35. Steup WH, De Leyn P, Deneffe G, Van Raemdonck D, Coosemans W, Lerut, T. Tumors of the esophagogastric junction. Long-term survival in relation to the pattern of lymph node metastasis and a critical analysis of the accuracy or inaccuracy of pTNM classification. J Thorac Cardiovasc Surg 1996; 111: 85-94. discussion 94-95.
36. Lerut T, Coosemans W, Decker G, De Leyn P, Ectors N, Fieuws S, Moons J, Nafteux P, Van Raemdonck D. Extracapsular lymph node involvement is a negative prognostic factor in T3 adenocarcinoma of the distal esophagus and gastroesophageal junction. J Thorac Cardiovasc Surg 2003; 126: 1121-1128.
37. Rüdiger Siewert J, Feith M, Werner M, Stein HJ. Adenocarcinoma of the esophagogastric junction: results of surgical therapy based on anatomical/topographic classification in 1,002 consecutive patients. Ann Surg 2000; 232: 353-361.